PFDSELECT MEDICAL RECEIVABLES Files D/A Amendment

TL;DR

**PFDSELECT MEDICAL RECEIVABLES filed a D/A, likely a minor administrative update to an exempt offering.**

AI Summary

PFDSELECT MEDICAL RECEIVABLES 1010, LLC filed a D/A (amendment to a Notice of Exempt Offering) on March 24, 2026, updating a previous filing. This filing, with an effectiveness date of March 24, 2026, indicates a minor administrative change to an exempt securities offering. For investors, this likely means the company is making a technical correction to its fundraising disclosures, which typically has no direct impact on the stock's value or the company's operations.

Why It Matters

This D/A filing is an administrative update to an exempt offering, suggesting a technical correction rather than a new financial event, and is unlikely to affect current or prospective investors.

Risk Assessment

Risk Level: low — The filing is an amendment (D/A) to an exempt offering, which typically involves minor administrative or technical corrections and does not signal significant financial risk or opportunity.

Analyst Insight

An investor should view this D/A filing as a routine administrative update, not a material event. No immediate action is required, but one could review the original Form D if details of the exempt offering are of interest.

Key Numbers

• 2026-03-24 — Filing Date (the date the D/A form was filed)
• 2026-03-24 — Effectiveness Date (the date the amendment became effective)
• 021-515145 — File No. (the SEC file number for the offering being amended)

Key Players & Entities

• PFDSELECT MEDICAL RECEIVABLES 1010, LLC (company) — the filer of the D/A form
• 0002025629 (company) — the CIK (Central Index Key) for the filer

FAQ

Key Financial Figures

• $1 — enues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,
• $1,000,000 — No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,
• $5,000,000 — Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001
• $1,000,001 — e   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000
• $5,000,001 — $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
• $25,000,000 — $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001
• $25,000,001 — $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
• $50,000,000 — 5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,0
• $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $1
• $50,000,001 — 0,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   O

Filing Documents

• primary_doc.html (D/A)
• primary_doc.xml (D/A) — 7KB
• 0002025629-26-000003.txt ( ) — 8KB

From the Filing

Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type Corporation Limited Partnership   Limited Liability Company   General Partnership   Business Trust Other   Name of Issuer   PFDSELECT MEDICAL RECEIVABLES 1010, LLC Jurisdiction of Incorporation/Organization NEVADA   Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year) 2024 Yet to Be Formed           2. Principal Place of Business and Contact Information Name of Issuer   PFDSELECT MEDICAL RECEIVABLES 1010, LLC Street Address 1 Street Address 2   11500 S. EASTERN AVE. , SUITE#150     HENDERSON   NEVADA     89052   888 475 4748   3. Related Persons Last Name First Name Middle Name Ermoian Gary L Street Address 1 Street Address 2   429 13th Street       Modesto   CALIFORNIA   95354   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Gary L. Ermoian is an Executive Officer and Director of PFD Capital Partners, Inc., a Nevada corporation, which is the Manager of the Issuer. Last Name First Name Middle Name Pryke Robert E Street Address 1 Street Address 2   23161 Lake Center Drive, #100       Lake Forest   CALIFORNIA   92630   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Robert E. Pryke is an Executive Officer of PFD Capital Partners, Inc., a Nevada corporation, which is the Manager of the Issuer. Last Name First Name Middle Name Hansen Eric Street Address 1 Street Address 2   23161 Lake Center Drive, #100       Lake Forest   CALIFORNIA   92630   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Eric Hansen is an Executive Officer of PFD Capital Partners, Inc., a Nevada corporation, which is the Manager of the Issuer. 4. Industry Group   Agriculture Banking & Financial Services     Commercial Banking     Insurance   Investing     Investment Banking     Pooled Investment Fund   Other Banking & Financial Services   Business Services Energy     Coal Mining     Electric Utilities     Energy Conservation     Environmental Services     Oil & Gas     Other Energy Health Care     Biotechnology     Health Insurance     Hospitals & Physicians     Pharmaceuticals     Other Health Care                         Manufacturing Real Estate   Commercial   Construction   REITS & Finance   Residential Other Real Estate   Retailing Restaurants Technology   Computers   Telecommunications   Other Technology Travel   Airlines & Airports   Lodging & Conventions   Tourism & Travel Services   Other Travel Other        5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   Over $100,000,000   Decline to Disclose   Decline to Disclose   Not Applicable   Not Applicable   6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b)         Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c)     7. Type of Filing   New Notice Date of First Sale   2024-06-07   First Sale Yet to Occur   Amendment     8. Duration of Offering Does the Issuer intend this offering to last more than one year?   Yes   No     9. Type(s) of Securities Offered (select all that apply) Pooled Investment Fund Interests Equity Tenant-in-Common Securities Debt Mineral Property Securities Option, Warrant or Other Right to Acquire Another Security Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe)       10. Business Combination Transaction Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?   Yes   No Clarification of Response (if Necessary)       11. Minimum Investment Minimum investment accepted from any outside investor $   10000 USD 12. Sales Compensation Recipient   Recipient CRD Number None     (Associated) Broker or Dealer None (Associated) Broker or Dealer CRD Number  None     Street Address 1 Street Address 2             13. Offering and Sales Amounts   Total Offering Amount $ 23000000 USD Indefinite Total Amount Sold $ 22347772 USD Total Remaining to be Sold $ 652228 USD Indefinite Clarification of Response (if Necessary)      14. Investors

View Full Filing

View this D/A filing on SEC EDGAR